- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 07.08. | FDA tightens label of Valneva's chikungunya vaccine, lifts pause in older adults | ||
| 07.08. | Vor Bio hires commercial chief, reuniting ex-Sarepta colleagues in freshly rebuilt C-suite | ||
| 07.08. | Aurobindo acquires US drugmaker Lannett for $250M to bolster 'reshoring' effort | ||
| 07.08. | Indian API maker Garonit Pharma plans $46.1M antiseptic product plant in New York | ||
| 06.08. | Jazz's Modeyso becomes first FDA-approved drug for type of aggressive brain cancer | ||
| 06.08. | Werewolf Therapeutics celebrates 'Full Moon Moments' in clinical trial recruitment push | ||
| 06.08. | Editor's Corner: Even in its first year, Fierce Pharma Week feels different | ||
| 06.08. | Novo's outgoing CEO prepares to hand off business as sales threats from Lilly, GLP-1 compounders persist | ||
| 06.08. | Bayer's layoff count now at 12,000-plus as its fortunes begin to turn | ||
| 06.08. | BeOne, now a Swiss company, widens Brukinsa's BTK lead over AstraZeneca's Calquence | ||
| 06.08. | Supreme Group buys Pivot Design, bringing agency takeover tally to 9 in 18 months | ||
| 05.08. | Trump ups the ante on pharma tariffs, saying they will reach 250% | ||
| 05.08. | BioNTech cuts 90 more US jobs as the drugmaker hones pipeline focus | ||
| 05.08. | TV drug ad spending plummeted in July, while AbbVie's Skyrizi regained the lead | ||
| 05.08. | Currax cranks up Contrave campaigns, taking obesity ad national and telling patients' stories | ||
| 05.08. | Pfizer CEO touts 'extremely productive' talks with Trump administration as MFN pricing, tariff threats close in | ||
| 05.08. | BioMarin touts promising early result for potential Voxzogo successor | ||
| 05.08. | Vertex narrows near-term development plan for Journavx after FDA naysays broad label in neuropathic pain | ||
| 05.08. | Y-mAbs signs off on $412M sale to SERB Pharmaceuticals, sending shares up 100% | ||
| 05.08. | Novo Nordisk faces investor lawsuit over 'false and misleading' semaglutide sales projections | ||
| 04.08. | AbbVie flashes eye-opening results for Rinvoq in alopecia areata | ||
| 04.08. | Incyte's new CEO pledges 'fresh look' at business, outlines dealmaking strategy | ||
| 04.08. | Lilly confirms plan to sell NJ plant amid larger US production ramp-up | ||
| 02.08. | Regulatory tracker: AstraZeneca's Imfinzi stomach cancer expansion bid snags FDA priority review | ||
| 01.08. | Regeneron says Novo plant problems caused another CRL and will delay 2 Eylea decisions |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .